guangfa pharmaceutical innovation hybrid sponsored securities investment fund (hereinafter referred to as: guangfa pharmaceutical innovation hybrid sponsored a, code 017962) announced its latest net value on March 4, up 3.44.
Guangfa Pharmaceutical Innovation Hybrid Initiation A was established on August 8, 2023. The performance comparison benchmark is the yield of China Securities Medical and Health Index × 55% + the yield of Hang Seng Healthcare Index denominated in RMB × 20% + the yield of China Bond-New Comprehensive Wealth (Total Value) Index × 25%. The fund has gained 2.72 per cent since its inception, -1.54 per cent this year and 19.19 per cent in January.
The fund manager is Duan Tao. Duan Tao has managed (or proposed to manage) the fund since July 10, 2023, earning 2.72 per cent during his tenure.
According to the latest periodic report, the top ten stocks of the fund are as follows:
| Stock Code | Stock Name | Position Percentage | market value of positions (yuan) | ||
| 688301 | 5.93 | 8421 | 2.739 million | ||
| 301188 | glass | 4.64 | 119800 | 2.1432 million | |
| 688302 | Haichuang Pharmaceutical | 3.83 | 33982 | 1.7694 million | /tr>|
| 09995 | 3.19% | 43500 | 1.4763 million | ||
| 688117 | Shengnuo | 3.16%> | 51723 | 1.4586 million | |
| 603707 | jianyou shares | 1.83 | 56500 | 847500 | |
| 688139 | Haier Bio | 1.50 | 17076 | 691900 | |
| 301367 | Matheson | 1.40 | 5300 | ||
| 09966 | Corning-Jerry Pharma-B | 1.02% | 78000 | 469300 | |
| 603259 | td>1.02 | 6500 | 472900 |
Ticker Name
Percentage Change
Inclusion Date
